Zoetis (NYSE:ZTS) Shares Unloaded Sen. Markwayne Mullin

Senator Markwayne Mullin (R-Oklahoma) recently sold shares of Zoetis Inc. (NYSE:ZTS). In a filing disclosed on December 05th, the Senator disclosed that they had sold between $15,001 and $50,000 in Zoetis stock on November 10th.

Senator Markwayne Mullin also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of CSX (NASDAQ:CSX) on 11/10/2025.
• Purchased $50,001 – $100,000 in shares of Capital One Financial (NYSE:COF) on 11/10/2025.
• Purchased $15,001 – $50,000 in shares of Pentair (NYSE:PNR) on 11/10/2025.
• Sold $15,001 – $50,000 in shares of Berkshire Hathaway (NYSE:BRK.B) on 11/3/2025.
• Sold $50,001 – $100,000 in shares of T-Mobile US (NASDAQ:TMUS) on 11/3/2025.
• Sold $15,001 – $50,000 in shares of (NASDAQ:FI) on 11/3/2025.
• Purchased $250,001 – $500,000 in shares of Microsoft (NASDAQ:MSFT) on 11/3/2025.
• Sold $15,001 – $50,000 in shares of Chipotle Mexican Grill (NYSE:CMG) on 11/3/2025.
• Purchased $50,001 – $100,000 in shares of Intuitive Surgical (NASDAQ:ISRG) on 9/24/2025.
• Purchased $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 9/24/2025.

Zoetis Stock Performance

Zoetis stock opened at $118.69 on Friday. The business has a 50 day moving average of $133.77 and a 200-day moving average of $147.78. The company has a market capitalization of $52.31 billion, a P/E ratio of 19.98, a P/E/G ratio of 2.50 and a beta of 0.97. Zoetis Inc. has a 1 year low of $115.25 and a 1 year high of $181.85. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28.

Zoetis (NYSE:ZTS) last announced its earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.08. The business had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.42 billion. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.Zoetis’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period last year, the company earned $1.58 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities research analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend was Friday, October 31st. Zoetis’s dividend payout ratio is presently 33.67%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday, October 8th. Stifel Nicolaus decreased their target price on Zoetis from $140.00 to $130.00 and set a “hold” rating for the company in a research report on Tuesday, November 18th. KeyCorp began coverage on Zoetis in a research note on Thursday, November 20th. They set a “sector weight” rating on the stock. Argus restated a “buy” rating and set a $190.00 price target on shares of Zoetis in a research note on Tuesday, September 9th. Finally, Morgan Stanley dropped their price objective on shares of Zoetis from $211.00 to $175.00 and set an “overweight” rating on the stock in a research note on Monday, November 10th. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $178.89.

Institutional Trading of Zoetis

Large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its holdings in shares of Zoetis by 1.0% during the third quarter. Vanguard Group Inc. now owns 42,306,764 shares of the company’s stock worth $6,190,326,000 after buying an additional 419,777 shares in the last quarter. Geode Capital Management LLC grew its position in Zoetis by 0.9% during the 2nd quarter. Geode Capital Management LLC now owns 11,081,301 shares of the company’s stock worth $1,721,356,000 after acquiring an additional 95,294 shares during the last quarter. Polen Capital Management LLC increased its holdings in Zoetis by 17.6% during the 1st quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company’s stock valued at $1,448,401,000 after purchasing an additional 1,313,653 shares in the last quarter. Northern Trust Corp raised its position in Zoetis by 1.2% in the 1st quarter. Northern Trust Corp now owns 6,504,902 shares of the company’s stock valued at $1,071,032,000 after purchasing an additional 78,508 shares during the last quarter. Finally, Norges Bank acquired a new position in Zoetis in the second quarter worth $809,491,000. Hedge funds and other institutional investors own 92.80% of the company’s stock.

About Senator Mullin

Markwayne Mullin (Republican Party) is a member of the U.S. Senate from Oklahoma. He assumed office on January 11, 2023. His current term ends on January 3, 2027. Mullin (Republican Party) ran in a special election to the U.S. Senate to represent Oklahoma. He won in the special general election on November 8, 2022. Mullin is a member of the Cherokee Nation and one of four Native American members of the 116th Congress. At the age of 20, Mullin took over his father’s plumbing business. He is also a former professional mixed martial artist. Markwayne Mullin graduated from Stilwell High School. Mullin earned an associate degree in construction technology from Oklahoma State University Institute of Technology. His career experience includes owning and founding multiple businesses.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.